Clinicians in the ICU must proactively identify and manage drug-drug interactions to prevent life-threatening QT prolongation and torsades de pointes.
No takes yet. Share an insight, caveat, or question.
ICU teams must screen for QT-prolonging interactions; leaves open optimal prevention protocols pending prospective trials.
Smithburger et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: